PUBLIC COMPANY
save$GKOSGLAUKOS Corp
$GKOS158.55-0.01%Aliso Viejo, CA, USupdated 15h ago
community read0 votes
pipeline
13
marketed
1
phase 3
1
catalysts ytd
6
approvals ytd
2
recalls ytd
0
Pipeline(13)
view full pipeline →pipeline depth13 products
2Preclinical7Phase 21Phase 31Marketed2Unknown
Marketed
riboflavin 5'-phosphate sodium
Keratoconus
Phase 3travoprost ER
Ocular Hypertension
Prostaglandin F2-alpha receptor
Phase 2GLK-221
Keratoconus
Phase 2GLK-302
Presbyopia
Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
Phase 2GLK-321
Demodex Blepharitis
Phase 2GLK-401
Age Related Macular Degeneration
Phase 2IVMED-80
Keratoconus
Phase 2iLution travoprost
Ocular Hypertension
Prostaglandin F2-alpha receptor
Phase 2pilocarpine
Keratoconjunctivitis Sicca (Dry Eye)
Muscarinic acetylcholine receptor M1Muscarinic acetylcholine receptor M3
PreclinicaliDose Next Generation
Glaucoma
Preclinicaltriamcinolone acetonide SR
Diabetic Macular Edema
drugEPIOXA HD/EPIOXA KIT
keratoconus
Upcoming
Recent(90d)
view all catalysts →Active trials
- —iDose TR Administration in an Office-Based Surgery Setting
- phase2Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- phase4Travoprost Intraocular Implant + iStent Infinite
- phase3Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant
- phase2Evaluation of the Safety and Efficacy of GLK-321 in Subjects With Demodex Blepharitis
- —Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg
- phase2Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus
- phase4Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Insider activity
source: SEC Form 4🐶 Hiring Signal
next earnings Oct 28, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 26m ago
Found something off?
comments(0)
5-min edit window · permanent after that